1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Hemera Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) Intravitreal AAVCAGsCD59, Intravitreal Sham Injection - Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | Withdrawn | Hemera Biosciences | 2021-07-31 | 2021-05-10 |